Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144242 · ClinicalTrials.gov registry record · NA
Improving Antibiotic Use for ARIs in Urgent Care Clinics
A NA study of Ambulatory Care and Antibacterial Agents, sponsored by Daniel Livorsi.
- Active
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06144242 is a NA study of Ambulatory Care and Antibacterial Agents that is active but no longer recruiting, run by Daniel Livorsi. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06144242, a NA study of Ambulatory Care and Antibacterial Agents, is active but no longer recruiting, sponsored by Daniel Livorsi.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Many clinicians prescribe antibiotics for patients with acute respiratory infections even when antibiotics will not benefit the patient because the infection is due to a virus. To discourage this type of unnecessary antibiotic use, the investigators will assess whether it is helpful to give clinicians feedback on how often they prescribe antibiotics for respiratory infections in comparison to their peers. The investigators will perform this study across Urgent Care and QuickCare clinics within a single healthcare system.
Conditions Studied
Interventions
- BEHAVIORAL Feedback on RTD metric
Study Locations (1)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06144242
The ClinicalTrials.gov registry entry for NCT06144242 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daniel Livorsi, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ambulatory Care appearing as the primary indexed condition, and to 1 intervention - of which Feedback on RTD metric is the first listed.
NCT06144242 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT06144242 about?
NCT06144242 is a clinical study titled "Improving Antibiotic Use for ARIs in Urgent Care Clinics". Many clinicians prescribe antibiotics for patients with acute respiratory infections even when antibiotics will not benefit the patient because the infection is due to a virus. To discourage this type of unnecessary antibiotic use, the investigators will assess whether it is helpful to give clinicia...
What is the current status of trial NCT06144242?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-01-01. Estimated completion is 2026-05-31.
What conditions does trial NCT06144242 study?
This clinical trial studies the following conditions: Ambulatory Care, Antibacterial Agents.
What interventions are being tested in trial NCT06144242?
The interventions under investigation include: Feedback on RTD metric (BEHAVIORAL).
Who is sponsoring clinical trial NCT06144242?
This trial is sponsored by Daniel Livorsi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06144242 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ambulatory Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.